Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00102362 · ClinicalTrials.gov registry record · Phase 3
Job-Seekers Training for Patients With Drug Dependence - 1
A Phase 3 study of Substance-Related Disorders, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 3
- Development phase
- 627
- Enrollment target
- 13
- Study locations
NCT00102362: Completed Phase 3 study of Substance-Related Disorders, sponsored by Johns Hopkins University.
NCT00102362 is a Phase 3 study of Substance-Related Disorders that has completed, run by Johns Hopkins University. The registered enrollment target is 627 participants, below the 1,510-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (58% lower). The trial reports 13 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00102362, a Phase 3 study of Substance-Related Disorders, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 627 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of this study is to examine the effectiveness of a 12-hour basic job-training program designed to give drug abuse treatment patients the skills they need to find and secure a job and set vocational goals and methods for locating employment. The intervention to be evaluated is modeled after the Job Seekers' Workshop, which was manualized and has been tested in trials.
Conditions Studied
Interventions
- BEHAVIORAL Behavior Therapy
Study Locations (13)
Maryland
- Glenwood Life Counseling Center - Baltimore
- Man Alive - Baltimore
- Daybreak Rehabilitation Center - Baltimore
Massachusetts
- CAB Health and Recovery Services, Inc. - Danvers
- CAB Health Recovery-Salem Outpatient - Salem
Michigan
- Psychiatry and Behavioral Medicine Professionals I - Detroit
- Self Help Addiction Rehabilitation (SHAR), Inc. - Detroit
New Mexico
- Na'nizhoozhi Center, Inc. - Gallup
- Life Link - Santa Fe
California
- 14th Street Clinic - Berkely
Oregon
- New Directions, NW - Baker City
South Carolina
- Dorchester Alcohol and Drug Commission - Summerville
Virginia
- Chesterfield County CSB- Substance Abuse Services - Chesterfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 627 participants |
| Start Date | 2004-12 |
| Est. Completion | 2006-10 |
| Phase | Phase 3 |
What the finished NCT00102362 record still lists
NCT00102362 is an interventional study that assigns participants to a tested intervention. The registered 627 participants enrollment target is mid-sized for trials with a published cap, below the 1,510-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Substance-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Behavior Therapy is the first listed.
NCT00102362 lists 13 locations in 8 states (Maryland, Massachusetts, Michigan).
Frequently Asked Questions
What is clinical trial NCT00102362 about?
NCT00102362 is a clinical study titled "Job-Seekers Training for Patients With Drug Dependence - 1". The purpose of this study is to examine the effectiveness of a 12-hour basic job-training program designed to give drug abuse treatment patients the skills they need to find and secure a job and set vocational goals and methods for locating employment. The intervention to be evaluated is modeled aft...
What is the current status of trial NCT00102362?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 627 participants. The study started on 2004-12. Estimated completion is 2006-10.
What conditions does trial NCT00102362 study?
This clinical trial studies the following conditions: Substance-Related Disorders.
What interventions are being tested in trial NCT00102362?
The interventions under investigation include: Behavior Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00102362?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00102362 being conducted?
This trial has 13 study locations across California, Maryland, Massachusetts, Michigan, New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00102362's enrollment target sits among peer trials
627 7th of 58 higher than 52 of 58 other Substance-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
ACTIVE NOT RECRUITING · Phase 3
-
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
COMPLETED · Phase 3
-
Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders
COMPLETED · Phase 3
-
Women's Treatment for Trauma and Substance Use Disorders - 1
COMPLETED · Phase 3
-
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06040827 · 626 participants
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension
- NCT05349227 · 625 participants · NA
Comprehensive Outcomes for After Cancer Health
- NCT06103864 · 625 participants · Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- NCT06230510 · 625 participants · NA
Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia